FastForward Innovations sees progress across its portfolio

0
55
  • SEED Innovations NAV rises by a third as cannabis investments pay off
  • FastForward Innovations’ ups stake in Little Green Pharma after being ‘really impressed’ by firm
FastForward Innovations Limited - FastForward Innovations targets significant upside with portfolio of early stage tech firms

Quick facts: SEED Innovations Ltd

Follow

View company profile

SEED Innovations Ltd’s investment focus leans towards capitalising on the company’s knowledge in the cannabinoid wellness and medical cannabis arenas.

As the only AIM-quoted investor with direct exposure to pharmaceutical and medical cannabis, SEED continues to demonstrate its expertise in the sector, notably with two of its portfolio assets selling for a combined value of over $1bn.

SEED is focused on investing in a balance of early-stage opportunities that have an upcoming investment catalyst, and more mature investments that offer liquidity in the near term.

15 Jul 2021

SEED Innovations Limited () saw its net asset value jump by a third as the value of its medical cannabis and CBD-focused investments soared.

The company, formerly known as Fast Forward Innovations, disposed of its stakes in Kanabo Group for a 223% gain, Cellular Goods after a four-fold rise and booked a profit of GBP1.9mln on the sale of to Cureleaf.

Net asset value rose at the end of the year to March 2021 to 11.72p per share against 8,82p a year earlier.

Ed McDermott, chief executive said: “The year under review and post period end was fast-paced and filled with activity as we increasingly steered the business towards a new focus on the hyper-growth sectors of health, wellness, and medical cannabis, investing in several exciting new businesses and exiting others that reached liquidity events to generate notable returns.

Read more

07 Jul 2021

FastForward Innovations Ltd () said it invested a further GBP50,000 in cannabidiol (CBD) consumer goods group South West Brands (SWB) by way of a 12-month, 8% convertible loan note (CLN) as part of a funding round for SWB to raise GBP100,000.

The AIM-listed investment firm said the funds raised by SWB will support its plans to float on the London Stock Exchange. The latest investment takes the total invested by FFWD to date to GBP300,000.

Read more

06 Jul 2021

FastForward Innovations Ltd () has invested GBP175,000 in the research-led cannabis healthcare company, CiiTECH Limited.

The AIM-listed investor in fast-growing businesses participated in CiiTech’s fundraising, which saw the company issue GBP2.1mln of 10% convertible loan notes ahead of its planned reverse takeover of Fragrant Prosperity Holdings Limited ().

Read more

11 Jun 2021

‘s () Ed McDermott and Alfredo Pascual join Proactive London’s Katie Pilbeam to explain why they purchased a further 1.17mln shares in its portfolio firm (LGP). This was done through the Australian Stock Exchange at an average price of A$0.655 each which means it now holds shares equivalent to around 2% of LGP’s share capital.

McDermott says ‘they are doing exactly want we want them to do, hence we felt it was a good time to start buying, markets are a little softer at the moment so we took advantage of that’. Pascual adds, ‘we identified a listed company that is very well run and is growing rapidly and is constantly achieving new milestones’.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash…

FOR OUR FULL DISCLAIMER CLICK HERE

FastForward Innovations’ ups stake in Little Green Pharma after being…

FastForward Innovations Limited’s (LON:FFWD) Ed McDermott and Alfredo Pascual join Proactive London’s Katie Pilbeam to explain why they purchased a further 1.17mln shares in its portfolio firm Little Green Pharma Ltd (LGP). This was done through the Australian Stock Exchange at an average price…

on 11/6/21

3 min read

LEAVE A REPLY

Please enter your comment!
Please enter your name here